Amedisys ticks lower as DOJ trial to block UnitedHealth deal set for Oct. 27 or later

Amedisys (NASDAQ:AMED) edged lower by 1.2% after a judge tentatively set a date for the Dep. of Justice’s challenge of UnitedHealth’s (NYSE:UNH) planned $3.3 billion deal. U.S. District Judge James K. Bredar set the trial for October 27, though the trial